Proteins and Peptides

22 May 2007 Roche receives approvable letter for Mircera in the United States
22 May 2007 Intarcia Therapeutics Announces Presentation of Final Results from a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
19 May 2007 Curis Provides Update on BMP-7 Program
16 May 2007 Phylogica Generates Multiple Drug Candidates For Treatment Of Rheumatoid Arthritis
16 May 2007 OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Liquid Fibrin Sealant, Evicel(TM), For Use in Vascular Surgery
15 May 2007 Dyax Corp. Treats First Patient in Phase 2 Trial for On-Pump Cardiothoracic Surgery
15 May 2007 Actilyse(R) (alteplase) recommended by National Institute for Health and Clinical Excellence for treatment of acute ischaemic stroke
15 May 2007 Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
15 May 2007 Nautilus Biotech receives FDA approval for Phase 1 clinical trial in the USA for oral Belerofon(R), its long-lasting, Interferon-alpha drug
11 May 2007 Viropro Inc. and Intas Biopharmaceuticals Announce the Signature of a Binding MOU for the Development and Production of a Therapeutic Protein
10 May 2007 FDA Advisory Committee Reviews Data on IDM Pharma's Junovan(TM) (mifamurtide) for Treatment of Osteosarcoma
10 May 2007 Altus Pharmaceuticals Initiates Phase III Clinical Trials of ALTU-135 for Cystic Fibrosis Patients with Pancreatic Insufficiency
09 May 2007 Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials
09 May 2007 AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
09 May 2007 Multiferon(R) Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
08 May 2007 Pacgen Announces Positive Results from Phase I/II Trial of Novel Anti-Fungal Drug
08 May 2007 Viragen Reports Expression Breakthrough Using OVA(TM) System for Therapeutic Protein Production
04 May 2007 Insmed Announces Promising Results From IPLEX(TM) Phase II Myotonic
04 May 2007 Indevus Announces FDA Approval of SUPPRELIN(R)-LA
03 May 2007 RegeneRx Receives IND to Begin Cardiovascular Clinical Program
02 May 2007 Phosphagenics to commence insulin clinical trial in May
02 May 2007 Spectrum Announces Completion Of Target Enrollment In Ozarelix Phase 2b Trial In Benign Prostate Hypertrophy
01 May 2007 Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
01 May 2007 Sangamo BioSciences Announces Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
01 May 2007 RegeneRx Cleared to Initiate First Ophthalmic Phase 2 Clinical Trial in Diabetics Undergoing Eye Surgery

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top